                      [,1]                                                                   
Short marker names    "CD4loCCR3loCD8loCCR7lo"                                               
Ontology marker names "CD4 molecule, C-C chemokine receptor type 3, T cell receptor"         
                      "co-receptor CD8, C-C chemokine receptor type 7"                       
Experiment markers    "CD4,CCR3,CD8,CCR7"                                                    
Ontology exper. names "CD4 molecule, C-C chemokine receptor type 3, T cell receptor"         
                      "co-receptor CD8, C-C chemokine receptor type 7"                       
Successful Match?     "No"                                                                   
Marker ID             "1) PR_000001004, PR_000025402 2) PR_000001004 3) PR_000025402"        
Marker Label          "1) CD4 molecule, T cell receptor co-receptor CD8 2) CD4 molecule 3) T"
                      "cell receptor co-receptor CD8"                                        
Marker Key            "1) { CCR3lo, CCR7lo } CD4lo, CD8lo ( ) [ CD44 molecule-, KLRB1-like"  
                      "protein-, alpha-beta T cell receptor complex+, signal transducer"     
                      "CD24hi ] 2) { CCR3lo, CD8lo, CCR7lo } CD4lo ( CD8+ ) [ alpha-beta T"  
                      "cell receptor complexhi, CD69 molecule+ ] 3) { CD4lo, CCR3lo, CCR7lo" 
                      "} CD8lo ( CD4+ ) [ alpha-beta T cell receptor complexhi, CD69"        
                      "molecule+ ]"                                                          
Score (Out of 1)      "1) -0.333 2) -1.25 3) -1.25"                                          
Cell ID               "1) CL_0002039 2) CL_0002430 3) CL_0002431"                            
Cell Label            "1) immature NK T cell stage I 2) CD4-intermediate, CD8-positive"      
                      "double-positive thymocyte 3) CD4-positive, CD8-intermediate"          
                      "double-positive thymocyte"                                            
